What is American Bio Medica Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. American Bio Medica's interest expense for the
three
months ended in Mar. 2023 was $ -0.02 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.17 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. American Bio Medica's Operating Income for the
three
months ended in Mar. 2023 was $ -0.21 Mil. American Bio Medica's Interest Expense for the
three
months ended in Mar. 2023 was $ -0.02 Mil.
American Bio Medica did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
American Bio Medica Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Bio Medica (OTCPK:ABMC) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
American Bio Medica's Interest Expense for the
three
months ended in Mar. 2023 was $-0.02 Mil. Its
Operating Income
for the
three
months ended in Mar. 2023 was $-0.21 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2023 was $0.00 Mil.
American Bio Medica's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as
| American Bio Medica did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
American Bio Medica (American Bio Medica) Business Description
Traded in Other Exchanges
N/A
Address
122 Smith Road, Kinderhook, New York, NY, USA, 12106
American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Executives
| Stuart Steinberg |
10 percent owner |
85 BELLEVUE AVENUE, RYE NY 10580 |
| John J Moroney |
10 percent owner |
118 PEGASUS DR., JUPITER FL 33477 |
| Chaim Davis |
director |
2601 PINE TREE DRIVE, MIAMI BEACH FL 33140 |
| Peter Jerome |
director |
7 RIDGECREST AVE, LATHAM NY 12110 |
| Diane Generous |
director |
122 SMITH ROAD, KINDERHOOK NY 12106 |
| Melissa A Waterhouse |
officer: EVP, CCO, CORP SEC |
AMERICAN BIO MEDICA CORPORATION, 122 SMITH ROAD, KINDERHOOK NY 12106 |
| Mp Biomedicals Llc |
10 percent owner |
3 HUTTON CENTRE DRIVE, SUITE 100, SANTA ANA CA 92707 |
| Douglas Casterlin |
officer: Executive Vice President |
C/O MELISSA A. WATERHOUSE/ABMC, 122 SMITH ROAD, KINDERHOOK NY 12106 |
| Jean Neff |
director |
C/O ABMC, 122 SMITH ROAD, KINDERHOOK NY 12106 |
| Stefan Parker |
officer: Chief Financial Officer |
122 SMITH ROAD, KINDERHOOK NY 12106 |
| Carl A Florio |
director |
C/O HUDSON RIVER BANK & TRUST CO, PO BOX 76, HUDSON NY 12534 |
| Stan Cipkowski |
director |
300 S LAKE DR, STE 340, FISHKILL NY 12553 |
| Anthony G Costantino |
director |
122 SMITH ROAD, KINDERHOOK NY 12106 |
| Edmund M Jaskiewicz |
director, officer: President |
|
| Richard Koskey |
director |
C/O ABMC 122 SMITH ROAD, 122 SMITH ROAD, KINDERHOOK NY 12106 |
American Bio Medica (American Bio Medica) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABMC has been successfully added to your 